1-Methyl-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride, 95.0%, 100mg

2-(4-chloro-2,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

2,7-Dibromoquinoline, 95.0%, 1g

Mandatory signs in accordance with ISO 7010, Foot protection mandatory, 100 mm, 1 piece

4-Iodophenylacetic acid, 98.0%, 1g

Cyclopropanecarboxamide, N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-, 98%, 25mg

1-Bromo-2-(bromomethyl)butane, 95%, 250mg

2,4-Dibromonaphthalen-1-amine, 95.0%, 10g

(1H-benzimidazol-2-ylmethoxy)acetic acid hydrochloride, 95.0%, 500mg

(R)-(+)-TolBINAP>98.0%(HPLC)5g

4-Bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

Nicotinic Acid Hydrazide>98.0%(T)25g

3-Chloro-4-isopropoxybenzoic acid, 95.0%, 25g